These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2524396)
41. The mechanism of protective effect of diltiazem on reperfusion-induced arrhythmias in isolated rat heart. Mitani A; Kinoshita K; Toshima Y; Nakamura Y; Oe M; Fukamachi K; Sakamoto M; Kishizaki K; Tokunaga K Jpn Circ J; 1990 Jan; 54(1):117-25. PubMed ID: 2332928 [TBL] [Abstract][Full Text] [Related]
42. Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischaemia. Snoeckx LH; van der Vusse GJ; Coumans WA; Willemsen PH; van der Nagel T; Reneman RS Cardiovasc Res; 1986 Jan; 20(1):67-75. PubMed ID: 2939955 [TBL] [Abstract][Full Text] [Related]
43. Improvement in contractile recovery of isolated rat heart after cardioplegic ischaemic arrest with endogenous phosphocreatine: involvement of antiperoxidative effect? Conorev EA; Sharov VG; Saks VA Cardiovasc Res; 1991 Feb; 25(2):164-71. PubMed ID: 1742767 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of ischemia-induced subcellular redistribution of lysosomal enzymes in the perfused rat heart by the calcium entry blocker, diltiazem. Ichihara K; Haneda T; Onodera S; Abiko Y J Pharmacol Exp Ther; 1987 Sep; 242(3):1109-13. PubMed ID: 3656110 [TBL] [Abstract][Full Text] [Related]
45. 31P nuclear magnetic resonance study of the effects of the calcium ion channel antagonist fantofarone on the rat heart. Vander Elst L; Chatelain P; Manning AS; Laruel R; Van Haverbeke Y; Muller RN Eur J Pharmacol; 1994 Jan; 251(2-3):163-72. PubMed ID: 8149974 [TBL] [Abstract][Full Text] [Related]
46. Is potassium channel opening an effective form of preconditioning before cardioplegia? Menasché P; Mouas C; Grousset C Ann Thorac Surg; 1996 Jun; 61(6):1764-8. PubMed ID: 8651781 [TBL] [Abstract][Full Text] [Related]
47. Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart. Nasa Y; Ichihara K; Abiko Y J Pharmacol Exp Ther; 1990 Nov; 255(2):680-9. PubMed ID: 2243348 [TBL] [Abstract][Full Text] [Related]
48. Tissue osmolality, metabolic response, and reperfusion in myocardial ischemia. Krieger WJ; ter Welle HF; Fiolet JW; Janse MJ Basic Res Cardiol; 1984; 79(5):562-71. PubMed ID: 6508714 [TBL] [Abstract][Full Text] [Related]
49. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. Gaasch WH; Zile MR; Hoshino PK; Weinberg EO; Rhodes DR; Apstein CS Circulation; 1990 May; 81(5):1644-53. PubMed ID: 2139593 [TBL] [Abstract][Full Text] [Related]
50. Adenosine antagonism decreases metabolic but not functional recovery from ischemia. Angello DA; Headrick JP; Coddington NM; Berne RM Am J Physiol; 1991 Jan; 260(1 Pt 2):H193-200. PubMed ID: 1992797 [TBL] [Abstract][Full Text] [Related]
51. Vascular washout reduces Ca2+ overload and improves function of reperfused ischemic hearts. Tani M; Neely JR Am J Physiol; 1990 Feb; 258(2 Pt 2):H354-61. PubMed ID: 2309903 [TBL] [Abstract][Full Text] [Related]
52. Effects of a new antianginal agent, nicorandil, on the cardiovascular system of the miniature pig: with special reference to coronary vasospasm. Sakai K; Akima M; Shiraki Y; Hoshino E J Pharmacol Exp Ther; 1983 Oct; 227(1):220-8. PubMed ID: 6225867 [TBL] [Abstract][Full Text] [Related]
53. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection? Menasché P; Kevelaitis E; Mouas C; Grousset C; Piwnica A; Bloch G J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1606-13; discussion 1613-4. PubMed ID: 8523870 [TBL] [Abstract][Full Text] [Related]
54. Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions. Vander Elst L; Goudemant JF; Mouton J; Chatelain P; Van Haverbeke Y; Muller RN J Cardiovasc Pharmacol; 1990 Mar; 15(3):377-85. PubMed ID: 1691360 [TBL] [Abstract][Full Text] [Related]
55. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. Lamping KA; Warltier DC; Hardman HF; Gross GJ J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374 [TBL] [Abstract][Full Text] [Related]
56. Nipradilol, a beta-adrenoceptor antagonist having a vasodilatory action, attenuates myocardial acidosis induced by coronary artery occlusion in dogs. Hino T; Hayase N; Chiba K; Ichihara K; Abiko Y Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):373-8. PubMed ID: 2568518 [TBL] [Abstract][Full Text] [Related]
57. The relationship between coronary pressure during reperfusion and myocardial recovery after hypothermic cardioplegia. Rosenfeldt FL; Rabinov M; Little P; Campbell G J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 1):414-24. PubMed ID: 3489137 [TBL] [Abstract][Full Text] [Related]
58. Coronary vasodilatory action after a single dose of nicorandil. Suryapranata H; Serruys PW; De Feyter PJ; Verdouw PD; Hugenholtz PG Am J Cardiol; 1988 Feb; 61(4):292-7. PubMed ID: 2963519 [TBL] [Abstract][Full Text] [Related]
59. Rebound recovery of myocardial creatine phosphate with reperfusion after ischemia. Ichihara K; Abiko Y Am Heart J; 1984 Dec; 108(6):1594-7. PubMed ID: 6507271 [No Abstract] [Full Text] [Related]
60. Atenolol depresses post-ischaemic recovery in the isolated rat heart. Allibardi S; Merati G; Chierchia S; Samaja M Pharmacol Res; 1999 Jun; 39(6):431-5. PubMed ID: 10373241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]